Medytox Venture Investment
- Company typePrivate
- Founded2017
- HeadquartersSeoul, South Korea
- Headcount1–10
- GTM typeB2B
- OfferingServices
Medytox Venture Investment firmographics
Firmographics- Name
- Medytox Venture Investment
- Website
- https://medytoxventure.com
- Company type
- Private
- Founded year
- 2017
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where Medytox Venture Investment is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Markets served
Medytox Venture Investment business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
Medytox Venture Investment product offering
Product offeringCore offering
Medytox Venture Investment is a TIPS (Tips for Investment in Promising Startups) operator that identifies, invests in, and supports growth-stage ventures primarily within the healthcare sector. The firm deploys capital and provides managerial support to help healthcare startups scale, leveraging the Korean government's TIPS program framework to source and develop promising ventures.
Differentiator
Problem solved
Functional benefit
Products and services
- Healthcare Venture Investment Program
Companies that use Medytox Venture Investment
Customer profileIdeal customer profiles1 record
Medytox Venture Investment technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Medytox Venture Investment competitors and assessment
Company assessmentDirect peers
- DSC Investment: Korean venture capital firm investing across technology and healthcare/life sciences sectors. A directly comparable domestic competitor for TIPS-style early-stage healthcare deals.
- Atinum Investment: Korean early- and growth-stage venture capital firm with active healthcare and life sciences investing. Comparable in stage focus and Korean market positioning.
- Primer Ventures: Korea-based early-stage venture capital firm with a life sciences and healthcare focus. Directly comparable in stage, sector, and geography to Medytox Venture Investment.
- IMM Investment: Korean venture capital and private equity firm with a dedicated biotech and healthcare investment team. Closely comparable by mandate, stage, and geography.
- LB Investment: Korean venture capital and private equity firm with a notable healthcare and biotech franchise. Competes directly with Medytox Venture Investment for early-stage healthcare deals in Korea.
- Korea Investment Partners: One of Korea's largest venture capital and growth equity firms with active healthcare and biotech investment activity. Highly comparable as a domestic Korean VC operating in the same ecosystem and competing for similar healthcare deals.
Broad incumbents
- KB Investment: Korean venture capital and private equity arm of KB Financial Group with active healthcare investment activity. Larger incumbent operating in the same healthcare startup ecosystem.
- Samsung Venture Investment: Corporate venture arm of Samsung with active investments in Korean biotech, digital health, and medical devices. Comparable as a larger incumbent capital provider overlapping in the same healthcare verticals.
- Korea Development Bank (KDB) — Healthcare Investing Arm: Korean state-owned policy bank with a dedicated life sciences and healthcare investment unit that co-invests in domestic biotech ventures. Functions as a broader incumbent capital source that interacts with the same founder pool.
- Celltrion Investment: Strategic investment vehicle tied to Celltrion, one of Korea's largest biosimilars and biotech players. Operates as an incumbent strategic investor in Korean healthcare startups and spinouts.
Market position
Customer concentration
Medytox Venture Investment financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medytox Venture Investment leadership team
Management profileNumber of profiles
Medytox Venture Investment funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medytox Venture Investment M&A and investment
M&A and investmentM&A
Investments25 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medytox Venture Investment
What does Medytox Venture Investment do?
Medytox Venture Investment is a TIPS (Tips for Investment in Promising Startups) operator that identifies, invests in, and supports growth-stage ventures primarily within the healthcare sector. The firm deploys capital and provides managerial support to help healthcare startups scale, leveraging the Korean government's TIPS program framework to source and develop promising ventures.
When was Medytox Venture Investment founded?
Medytox Venture Investment was founded in 2017. It employs 1 to 10 people.
Where is Medytox Venture Investment based?
Medytox Venture Investment is headquartered in Seoul, South Korea, in the Asia region.
Who are Medytox Venture Investment's main competitors?
Direct peers on record are DSC Investment, Atinum Investment, Primer Ventures, IMM Investment, LB Investment and Korea Investment Partners. Broad incumbents are KB Investment, Samsung Venture Investment, Korea Development Bank (KDB) — Healthcare Investing Arm and Celltrion Investment.
Does Medytox Venture Investment have an API?
No public API is recorded for Medytox Venture Investment.